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ABSTRACT:
Background: Stroke severity is one of the factors that determines stroke related disability. We explored possible
associations between stroke severity and commonly evaluated clinical parameters of stroke patients.
Objective: To determine the relationships between clinical features including routine in- hospital investigations done
in first 24 hours of admission and variations in the stroke severity.
Patients and Methods: This was a retrospective, analytical study performed in the Department of Neurology at Shifa
International Hospital, Shifa Tameer-e-Millat University, Islamabad, Pakistan. Adult patients admitted with ischemic
stroke, over a period of 39 months, with Middle Cerebral Artery infarctions, were included. National Institute of Heath
Stroke Scale (NIHSS) score was taken as a measure of stroke severity. The pertinent information was filled in a
predesigned data sheet, and analyzed using SPSS version 20.0.
Results: A total of 207 patients were included in the study. The highest stroke severity was found in old age ([>64
years]), and patients with cardio embolic and unclassified (> one etiology) strokes, while the lowest severity was found
in small artery occlusion strokes. Higher fasting serum triglyceride levels were associated with lower stroke severity and
vice versa ([P=.002]). Among supra aortic large artery atherosclerosis the pre-stroke anti-platelet ([52 %]) and beta
blocker use ([53.6 %]) was significantly associated with lower stroke severity. In cardio embolic strokes active smoking
was associated with increased severity ([90%]).
Conclusion: Stroke severity is not only related to stroke etiology, but also, age, fasting serum triglyceride levels, active
smoking and pre-stroke medications may also play significant roles. Nevertheless, further studies are required with
prospective design, to confirm our findings.
Key words: infarction; middle cerebral artery; lacunar; hypertriglyceridemia; stroke severity; NIHSS score;
atherosclerosis.

INTRODUCTION: Acute ischemic stroke is considered
as one of the most common fatal diseases, in our
times.1 Those who survive strokes, suffer from their
undesirable outcomes that include the subsequent
long-term or sometimes life-long disability 1 which
constitutes a significant burden on patients’ personal
well-being and on the care givers as well. Stroke
severity is one of the factors associated with disability 2.
Stroke severity can be assessed and measured by
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clinical examination. There are many scoring systems
that quantify or measure stroke severity. One of these is
National Institute of Health Stroke Scale (NIHSS),
which is a validated and a widely used scoring system
for this purpose.3 Currently, acute thrombolysis,
revascularization, prophylaxis (preventing first or further
strokes) and rehabilitation are the main domains of
stroke therapy. We believe that identifying reversible
factors that may play a role in reducing stroke severity
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reviewed and analyzed by a consultant neurologist and
statisticians.

may give us clues to look for novel neuroprotection and
possibly disease modifying strategies. We designed our
research work as an exploratory study, aiming to
observe relationships between the clinical, laboratory
and radiological features, and stroke severity among
ischemic stroke patients. We identified clinical
characteristics that are usually evaluated for nearly all
hospitalized patients suffering ischemic stroke, and
analyzed them for any significant relationship with
stroke severity as measured by NIHSS. Given possibility
of confounding factors and limitations of NIHSS we
restricted our study only for ischemic strokes in middle
cerebral artery ([MCA]) distribution.

Operational definitions:
1. Acute MCA ischemic stroke: An acute event that was
diagnosed by the attending neurologist as ischemic
stroke ([with or without hemorrhagic conversion]) and
corresponds to areas supplied by middle cerebral artery
and/ or its smaller perforator branches which was
further radiologically confirmed by MRI ([DWI/ ADC
sequences]) or CT scans.
2. Co- morbid hypertension: The file records showed
that the patient was known to be hypertensive and he
was on regular anti-hypertensive therapy, or was found
to have a blood pressure of 160 mmHg / 90 mmHg or
more on admission, that was not considered by the
attending physician as transient rise due to cerebral
compensating mechanisms.

METHODS:
This study was designed as an exploratory retrospective
cross sectional survey. It was carried out in the
department of Neurology, at Shifa International
Hospital, Islamabad, Pakistan which is one of the
largest tertiary care hospitals in the capital city. The
research protocol was approved by the Institutional
Review Board of the same hospital. Only adult patients
([18 years and above]) admitted in the neurology
service, with the diagnosis of acute Middle Cerebral
Artery (MCA) ischemic stroke (territorial or lacunar
infarcts in MCA distribution), within three days of onset
of ischemic symptoms over a period of 39 months
([September 2009 to November 2012]) were
considered. During the study period Intravenous tissue
plasminogen
activator,
acute
endovascular
intervention, were not available in our hospital,
therefore none of the patients received acute
thrombolytic therapy. Patients with posterior circulation
ischemia, having history of previous stroke, and those
suffering from any disabling neurological disease other
than stroke were excluded as the patients with previous
strokes, and having a baseline neurological deficit may
have a more severe deficit, because of the recurrent
stroke, which may not be related to the more acute
laboratory findings that we measured. The file records
of selected patients were extracted and relevant clinical
information pertaining to first 24 hours of hospital
admissions was obtained. The laboratory values were
taken from Hospital Information System (HIS), and
radiological data was reviewed from Picture Archiving
and Communication System ([PACS]) of the hospital.
For etiological classification of stroke the online
Causative Classification of Ischemic Stroke ([CSS])
System was used 4. The information thus obtained was
entered in a predesigned data sheet. At the completion
of the data collection all the data was entered in SPSS
20. All the case histories, laboratory data in first 24
hours of admission, and radiological information was
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3.
Co- morbid diabetes: The file records showed
that the patient was known to be diabetic and he/ she
was taking regular anti diabetic medications, or his
HbA1c was 6.5 % or more.
4.
Co – morbid Ischemic heart disease and
chronic renal failure: The patient was labelled to have
above mentioned co-morbid conditions in the file
records, diagnosed on the basis of clinical,
electrocardiographic, biochemical, echocardiographic
and ultra-sonographic investigations.
Categories by stroke etiology / stroke type:
We utilized the online software, CCS ([which is derived
from TOAST classification]) to determine the stroke type
by its etiology. 4 However we made some modifications
in this classification system, so that statistical analyses
were possible as some of the categories had very low
number of patients. In the original CCS classification
there are 5 major categories and 4 subcategories. But,
in our study we merged some of the subcategories and
thus made in total 6 categories ([without any
subcategories]) at the time of analyses of the data
([table 1]). The subtype “unknown – cryptogenic
embolism” and “unknown- other cryptogenic” in CCS
were also combined together into cryptogenic type. The
category “Unclassified” was used when more than one
etiologies are identifiable in the same patient ([same as
in original CCS classification]).
Categories by stroke severity:
Determined by NIHSS score. They were as follows5 ;
Mild: < 5, Moderate: 5- 14, Severe: ≥ 15
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Statistical analysis:

category in cardio embolic strokes ([mean NIHSS
10.4]) and unclassified ([mean NIHSS 9.3]) stroke
types. Small vessel occlusion type strokes had the
lowest severity. When stroke severity ([mean NIHSS
and/or NIHSS categories]) was compared with all
variables other than stroke etiology, significant
associations were found only with age and fasting
triglyceride levels. Stroke severity was found to be
higher with advancing age.
NIHSS scores were
significantly lower with higher triglyceride levels and vice
versa. ([see table 2 and figure 2]). When radiological
features were compared to stroke severity ([Table 3]) it
was found that higher stroke severity was associated
with whole MCA territory / malignant MCA infarctions,
while partial MCA infarctions were less severe. MRI DWI
(Diffusion Weighted Imaging) assessment showed that
large sized infarctions with more than 15 mm size
([territorial, lobar or deep subcortical]) and those with
hemorrhagic conversion, were more likely to be
moderate or severe.

Data analysis was done by using SPSS version-20.0
([IBM Product-USA]). The categorical response
variables included patient’s demographic features,
etiology of stroke, co- morbid conditions, family history,
clinical features and severity of stroke. The numeric
response variables like fasting triglyceride and other
lipid levels, HbA1c, random blood sugar ([RBS]),
Systolic Blood Pressure, and fasting lipid profile were
presented as mean (standard deviation). Analysis of
variance ([ANOVA]) was performed to compare these
numeric response variables. Later, these numeric
variables were stratified in order to control the
confounding effect and effect modifiers. Stroke severity
was also stratified into three categories i.e., mild,
moderate and severe. Bivariate analysis by using
Chi-square test was done to see relationship of
aforementioned variables with the severity of stroke
measured by NIHSS and divided into categories.
Pearson’s correlation coefficient was calculated to see
the relationship of triglyceride level with the NIHSS.
P-value ≤.05 was considered statistically significant
result.

Sub category analysis ([stroke severity analysis by
stroke etiology]):
We analyzed the relationship of different variables with
stroke severity categories, in each stroke type / etiology.
In this analysis we found that only the Supra Aortic
Large artery atherosclerosis and cryptogenic types
([Table 4]) had the inverse relationship between stroke
severity and triglyceride levels ([P = .04]). Apparently
triglyceride levels did not produce similar effect on
stroke severity in cardio aortic embolism and small
vessel occlusion. In this sub category analysis, we also
found that the pre-stroke anti platelet ([aspirin,
clopidogrel or both]) and beta blocker use ([Table 5])
was significantly associated with lower stroke severity
only in Supra Aortic Large artery atherosclerosis
([P=.02]). In cardio aortic embolic strokes 10 patients
were actively smoking out of which 6 patients suffered
from severe stroke, 3 patients with moderate stroke
and only one had mild stroke ([P=.03]).

RESULTS:
Baseline characteristics of patients:
Total 207 patients were selected after applying the
inclusion and exclusion criteria. The mean ([SD]) age of
patients was 63.5 ([13.7]) yrs. ([range 26 yrs. – 95
yrs.]). There were 117 ([56.5 %]) males and 90 ([43.5
%]) females. Among males mean ([SD]) age was 64.1
([13.6]) yrs., and that of females was 62.8 ([13.8])
yrs.The age distribution was not uniform among
different stroke etiologies. The mean age in unclassified
stroke type ([more than one etiologies]) was 70 yrs.
that was highest than the rest of stroke types, while the
mean age in uncommon causes of stroke was 34 years
that was significantly lower than the other stroke types.
According to stroke etiology most of the patients were
in supra aortic large artery atherosclerosis that totaled
98 ([47.3%]) patients, followed by, Cardio embolism in
40 ([19.3%]) patients, small artery occlusion in 22
([10.6 %]) patients, cryptogenic type in 21 ([10.1 %]),
unclassified in 20 ([9.7 %]), and uncommon causes in
5
([2.4 %]), of patients. One patient had incomplete
evaluation.

DISCUSSION:
In this exploratory study we compared many different
characteristics of patients with acute ischemic stroke
and analyzed them for their relationship with stroke
severity. The stroke etiology / type, as is already known,
was one of the main factors related to stroke severity
([table 1]). The cardio aortic embolism and unclassified
type (more than one etiology) were associated with
more severe strokes, while supra aortic large artery
atherosclerosis mostly with moderate severity and
cryptogenic strokes, small artery occlusion, and

Stroke severity analysis:
When stroke severity was taken as mean NIHSS or as
NIHSS categories ([mild, moderate or severe]), the
results appeared similar (see Table 1 and figure 1).
Higher number of patients were in moderate to severe
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more incident stroke but that of lesser severity.(3) There
is also a possibility that high lipids especially
triglycerides, may have a more positive role in acute
ischemic strokes. It is a well-known fact that fats in
general have a favorable effect on brain metabolism.
For example; fatty diets like ketogenic diet is well known
to have a therapeutic effect in refractory epilepsy in
children, 14 although similar diet has not been
thoroughly evaluated in adults with stroke or epilepsy.
Thus more research is needed to elucidate the role of
lipids/ triglycerides in during the acute phases of
ischemic stroke. In supra aortic large artery
atherosclerotic strokes pre stroke antiplatelet (aspirin,
clopidogrel or both) and beta blocker use was
significantly associated with lower stroke severity
([table 5]). Aspirin use before stroke has been shown to
have a beneficial effect in some other studies as similar
findings were reported by Park etal 15 in
atherothrombotic stroke. Same effect could not be
seen in cardio aortic embolism and other stroke types
16,17
. The effect of beta blockers (propranolol and
carvedilol) on brain ischemia has been shown in
experimental models of stroke that suggest a
neuroprotective effect on cerebral neurons18-20.
Dziedzic T et al, found lower rates of early mortality after
ischemic stroke in patients taking beta blockers,
however, they did not report any effect on stroke
severity22. They did not take stroke etiology into
account, in their patients. Active current smoking was
also found to be related to increased stroke severity in
cardioembolic stroke but not in other types. Similar
findings were reported by Edjoc etal.22 Among the
radiological features, it was the size and not the site of
the infarction that was mainly associated with stroke
severity ([table 3]). In plain CT brain and MRI scans the
whole MCA territory and malignant MCA infarctions had
significantly higher stroke severity, while among the
different MRI DWI patterns we found only the large ([>
15 mm in size]) pattern irrespective of the location
(lobar or deep subcortical) had significant association
with severe strokes.

uncommon causes were associated with predominantly
lower stroke severity. Similar results have been shown
in other studies6,7. Furthermore the triglyceride levels
were found to be inversely related to stroke severity, as
the higher triglyceride levels were significantly
associated with lower stroke severity and vice versa
([table 2 and figure 2]). In fact, the role of higher serum
triglycerides in reducing the stroke severity is a relatively
novel concept, as hypertriglyceridemia is considered a
risk factor for stroke. The association of triglyceride
levels in blood, with stroke severity and outcome has
emerged in a few other recently published studies8.
Dziedzic et al., correlated the Scandinavian stroke scale
([which is another measure of stroke severity]) to
triglyceride levels, and concluded that lower triglyceride
levels were associated with increased stroke severity9.
A prospective study by Ryu etal, reported that higher
fasting triglycerides on admission predict less disability,
reduced disability progression, and all-cause mortality
in patients with acute ischemic stroke10. Another study
by Choi etal also confirmed that low serum triglyceride
level is an independent predictor of mortality after
ischemic stroke, but noted that this association did not
hold true in the subgroup with cardioembolic stroke11.
History of dyslipidemia was found to have a favorable
effect on out come in ischemic stroke patients in Kyoto
stroke registry12. In one study higher cholesterol levels
were also reported to be associated more frequently
with minor strokes13. Our study elaborates this unusual
phenomenon, as we further analyzed the distribution of
triglycerides levels among different stroke severity
categories in each stroke etiology/ type. What appeared
in this later analysis is that the effect of serum
triglyceride levels (as mentioned above) was significant
only in supra aortic large artery atherosclerosis and
cryptogenic types (table 4). The other types including
cardioaortic embolic and small artery occlusion stroke
types were not affected by triglyceride levels. The loss
of this triglyceride effect in cardio aortic embolic strokes
was also seen by Choi etal ([see above])11. Current
stroke pathophysiology models do not explain this
phenomenon, as hypertriglyceridemia is actually
considered a risk factor for stroke because of its long
term effects on vascular endothelium. There can be
many explanations for this associations. (1) Some
authors consider serum triglycerides as an acute phase
reactant that is decreased in severe strokes as a result
of cerebral ischemia and perhaps may not actually have
a direct protective effect against cerebral neuronal
damage8. (2) Another likely possibility, though
debatable, is the fact that high lipid containing plaque /
clot is very likely to be friable, and thus embolise easily
into more distal cerebral vasculature thus it may cause
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Weaknesses:
The study was a retrospective analysis with an
exploratory design. We preferred such a study design
because; (1) we were not testing any hypothesis, rather
we aimed to look into possible novel strategies for
neuroprotection
that
might
generate
newer
studies.(2)The authors found it more feasible because
of the limited resources at their disposal. Furthermore,
a multivariate analysis could not be performed for
specification of potential confounding effect and
predictors of stroke severity due to design of study.
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Rather, we used restriction and stratification
strategies in data selection and analysis to control for
possible confounders.
We also did not have the pre stroke or baseline
triglyceride levels of our subjects, which was
practically not possible either, therefore the theory of
acute phase reaction to explain the inverse
triglyceride relationship with stroke severity could not
be evaluated.

*Shows statistically significant proportion of severity
of stroke with stroke types (P<.001)
Figure 1 : Mean NIHSS score Difference
according to stroke etiology

Strengths:
In spite of all the weaknesses we think that this study
provides valuable information. Furthermore we
analyzed our variables in different subsets and found
that the relationship between stroke severity and
triglyceride levels, pre-stroke anti platelet as well as
beta blocker use and smoking, seemingly depends
upon the etiological category of the stroke, a fact not
particularly looked into as yet.

Bar graph showing significant mean NIHSS score
associated with stroke sub-types ([F= 6.317,
P=.001]). Cardio aortic embolic strokes and
unclassified strokes had the highest severity.

CONCLUSION:

Table 2 : stroke severity as compared to different
variables:

Stroke severity is related to age and its etiology. There
is also a possible inverse correlation between stroke
severity and fasting triglyceride levels, which is seen
predominantly in supra aortic large artery
atherosclerotic and cryptogenic stroke etiologies.
People who suffer ischemic strokes due to supra
aortic large artery atherosclerosis, with pre-stroke use
of anti-platelets and beta blockers, also seem to have
a reduced stroke severity. Furthermore, patients who
actively smoke may have more severe strokes, if they
have a cardio embolic etiology. We would recommend
future studies to verify if factors we found have a
consistent causal association, in the context of
different stroke etiologies.

Demographics

Mild

Moderate

Severe

P – value

Mean age

60.6

65.7

64.5

.04

Female

31 (34.4%)

45 (50 %)

14 (15%)

.25

Male

48 (41%)

45 (38.4 %)

24 (20.5%)

Occupational Employed
status
Unemployed

16 (53.3 %)

8 (26.7%)

6 (20%)

52 (32.7%)

75(47.1%)

32(20.1%)

Marital status

Single

0 (0%)

3 (75 %)

1 (25 %)

Married

67 (40 %)

70 (41.6%)

31 (18.5 %)

Widow

6 (25 %)

13 (54.2 %)

5 (20.8 %)

Diabetes mellitus

41 (40 %)

42 (41.1 %)

19 (18.6 %)

.40

Hypertension

57 (40.4%)

58 (41%)

26 (18.4%)

.60

Ischemic heart disease

14 (29.2%)

20 (41.7%)

14 (29.2%)

.07

Smoking (current)

20 (37.7 %)

19 (35.8%)

14 (26.4 %)

.18

Chronic renal failure

4 (57.1 %)

2 (28.6 %)

1 (14.3%)

.57

Systolic BP (mean value
during first 6hrs of
presentation)

142.2

142.95

144

.91

RBS

177.25

155.77

170.86

.31

HbA1c

7.8

7.51

8.64

.14

Triglycerides

196

145.5

137.7

.002

Total cholesterol

172.5

180.5

186.5

.279

HDL cholesterol

35.5

39.1

38

.120

LDL cholesterol

109.5

117.5

127.7

.065

Sex

.07

.35

Co- morbid conditions

Table 1: stroke severity by categories vs stroke
etiology.

Other baseline values (means)

Stroke etiology

NIHSS at admission categorized
Mild (<5)

Supra aortic Large artery
atherosclerosis
Cardio aortic embolism

33 (33.7%)*

Moderate
(5-14)
44 (44.9%)*

Total

Severe (
15)
21 (21.4%)

98

8 (20.0%)

21(52.5%)*

11 (27.5%)*

40

Small artery occlusion

17 (77.3%)*

5 (22.7%)

0 (0.0%)

22

Cryptogenic type

13 (61.9%)*

8 (38.1%)

0 (0.0%)

21

unclassified

4 (20.0%)

10 (50.0%)*

6 (30.0%)*

20

Uncommon causes

3 (60.0%)

2 (40.0%)

0 (0.0%)

5

Total

78 (37.9%)

90 (43.7%)

38 (18.4%)

206
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Figure 2 : Scatter plot showing inverse relationship
between NIHSS at admission and triglyceride
levels

Table 5: impact of pre-stroke medicines and stroke
severity
Antiplatelet use :
Mild

Moderate

Severe

P-value

Supra aortic Large artery
atherosclerosis

14 (52 %)

6 (22.2 %)

7 (25.9 %)

.02a

Cardio aortic embolism

1 (10 %)

6 (60%)

3 (30%)

.12 a

Small artery occlusion

3 (60%)

2(40%)

0

.29 a

Cryptogenic

3 (100%)

0

0

.14 a

Unclassified

1 (14.3%)

5 (71.4%)

1 (14.3%)

.36 a

1 (50%)

1(50%)

0

.70 a

Mild

Moderate

Severe

P-value

15 (53.6 %)

10 (35.7%)

3 (10.7 %)

.02a

Cardio aortic embolism

4 (40 %)

3 (30 %)

3 (30%)

.66a

Small artery occlusion

2(50%)

2(50%)

0

.21b

Cryptogenic

3 (100%)

0

0

.21b

Unclassified

1 (14.3%)

5 (71.4%)

1 (14.3%)

.36a

0

1 (100%)

0

.59a

Uncommon causes
Beta- blocker use:

Table 3 : Radiological features vs stroke severity
Vascular territory

Mild

Moderate

Severe

(n = 78)

(n = 90)

(n = 38)

Lacunar infarct (MCA
perforator)

17 (21.8)*

7 (7.8)

0 (0)

.011

Partial MCA

54 (69.0)*

56 ( 62.2)

15 ( 39.5)

.018

Whole MCA

0 (0)

8 (8.9)

8 (21.0)*

.028

(CT and MRI brain)

Supra aortic Large artery
atherosclerosis

P- value

Uncommon causes

a Statistical significance using Pearson’s chi-square
test b Fischer’s exact test.

DWI patterns
Large ( > 15 mm)

6 (7.7)

38 (42.2)*

14 (36.8)*

.001

Small superficial

17 (21.8)*

2 (2.2)

0 (0.0)

.001

16(20.5)

21 (23.3)

7 (18.4)

.736

Small deep

7 (9.0)

3 (3.3)

0 (0)

.083

Water shed infarcts

7 (9.0)*

2 (2.2)

1 (2.6)

.046

Hemorrhagic conversion

1 (1.3)

4 (4.4)

4 (10.5)*

.007

Cortical mixed patterns

*significant values.
Table 4 : Mean Triglyceride levels in different
stroke categories
Stroke types

Mild

Moderate

Severe

P- value

Supra aortic large artery
atherosclerosis

212.18

149.00

156.42

.04

Cardio aortic embolism

142.71

133.72

116.45

.74

Small artery occlusion

174.75

184.60

--

.85

Cryptogenic

216.08

141.86

--

.04

Unclassified

152.00

111.78

107.25

.49
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